Read + Share
Amedeo Smart
Independent Medical Education
Soo RA, Cho BC, Kim JH, Ahn MJ, et al. Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis. J Thorac Oncol 2023;18:1756-1766.PMID: 37865896
Email
LinkedIn
Facebook
Twitter
Privacy Policy